Attovia Therapeutics, Inc.
- Biotech or pharma, therapeutic R&D
Attovia is creating a pipeline of biotherapeutics with an initial focus on bispecifics in immune-mediated disease. We leverage Attobody™, a novel platform, to generate half-life extended biparatopic binders with best-in-class potency.
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}